1987
DOI: 10.1016/s0009-9260(87)80413-0
|View full text |Cite
|
Sign up to set email alerts
|

The effect of intrathecal iohexol on visual evoked response latency: A comparison including incidence of headache with iopamidol and metrizamide in myeloradiculography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1988
1988
1995
1995

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…This has been demonstrated in comparative studies of iohexol and metrizamide using this animal model (7). These results predicted that using iohexol instead of metrizamide would lower the rate of minor side effects in myelography and this prediction has been confirmed in clinical comparative trials dealing with various aspects of adverse reactions during the last decade (2,3,6,9,14,16,17).…”
Section: Discussionmentioning
confidence: 66%
“…This has been demonstrated in comparative studies of iohexol and metrizamide using this animal model (7). These results predicted that using iohexol instead of metrizamide would lower the rate of minor side effects in myelography and this prediction has been confirmed in clinical comparative trials dealing with various aspects of adverse reactions during the last decade (2,3,6,9,14,16,17).…”
Section: Discussionmentioning
confidence: 66%
“…However, while the incidence of adverse reactions has indeed been reduced with the use of iopamidol and iohexol, even now up to 40 percent of patients have been reported to experience adverse reactions to myelography with either of these agents. 1,2 In order to further reduce patient discomfort following myelography, we attempted to identify risk factors which may have been associated with a higher incidence of side effects. Myelographic techniques, patient variables and post-myelographic symptoms were prospectively studied in a group of 152 patients undergoing iopamidol myelography, myelographic computed tomography (CT) or both, and in a second group of 28 patients undergoing similar studies with iohexol.…”
Section: Introductionmentioning
confidence: 99%